Riboflavin supplementation in children with riboflavin transporter deficiency type 2 does not stop disease progression based on long-term follow-up

Corresponding Author

Enrico Bertini

• [email protected]

• orcid.org/0000-0001-9276-4590

Research Unit of Neuromuscular and Neurodegenerative Disease, Bambino Gesu’ Children's Hospital, IRCCS, Rome, Italy

Keith Massey

Cure RTD, Riboflavin Transporter Deficiency Foundation, Calgary, AB, Canada